• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中脂质代谢失调及天然产物的作用

Dysregulation of lipid metabolism in chronic kidney disease and the role of natural products.

作者信息

Jiang Yang-Yi, Jiang Xiao-Li, Yu Hai-Ning

机构信息

College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, China.

Nephrology Department, Ningbo Medical Center Lihuili Hospital, Ningbo, China.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):261-278. doi: 10.1007/s00210-024-03373-4. Epub 2024 Aug 20.

DOI:10.1007/s00210-024-03373-4
PMID:39162795
Abstract

Dysregulation of lipid metabolism plays a key role in the onset and progression of CKD, and a thorough understanding of its regulatory mechanisms is essential for the development of effective treatments. In recent years, an increasing number of studies have focused on the pharmacological activities of natural products and their application in the treatment of chronic diseases. Natural products, including plant extracts and bioactive compounds, have been shown to exert anti-inflammatory, antioxidant, antifibrosis, and anti-apoptotic effects through various signaling pathways in the treatment of CKD. Many natural products have been shown to target dysregulated lipid metabolism through various signaling pathways. This review summarizes the key regulatory factors and signaling pathways involved in the dysregulation of lipid metabolism in chronic kidney disease (CKD), highlighting their importance as potential therapeutic targets. Recently published research on the potential therapeutic benefits of natural products for the treatment of CKD was described. These studies have revealed the multi-target role of natural products in the regulation of lipid metabolism. Natural products show great potential in targeting lipid metabolism-related pathways, offering a novel research direction for the treatment of CKD while providing a scientific basis and experimental support for the development of new treatment strategies.

摘要

脂质代谢失调在慢性肾脏病(CKD)的发生和发展中起关键作用,深入了解其调控机制对于开发有效的治疗方法至关重要。近年来,越来越多的研究聚焦于天然产物的药理活性及其在慢性病治疗中的应用。天然产物,包括植物提取物和生物活性化合物,已被证明在CKD治疗中可通过多种信号通路发挥抗炎、抗氧化、抗纤维化和抗凋亡作用。许多天然产物已被证明可通过多种信号通路靶向脂质代谢失调。本综述总结了慢性肾脏病(CKD)中脂质代谢失调所涉及的关键调控因子和信号通路,强调了它们作为潜在治疗靶点的重要性。描述了最近发表的关于天然产物治疗CKD潜在益处的研究。这些研究揭示了天然产物在脂质代谢调控中的多靶点作用。天然产物在靶向脂质代谢相关通路方面显示出巨大潜力,为CKD治疗提供了新的研究方向,同时为新治疗策略的开发提供了科学依据和实验支持。

相似文献

1
Dysregulation of lipid metabolism in chronic kidney disease and the role of natural products.慢性肾脏病中脂质代谢失调及天然产物的作用
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):261-278. doi: 10.1007/s00210-024-03373-4. Epub 2024 Aug 20.
2
The Potential of Naturally Derived Compounds for Treating Chronic Kidney Disease: A Review of Autophagy and Cellular Senescence.天然衍生化合物治疗慢性肾脏病的潜力:自噬与细胞衰老综述
Int J Mol Sci. 2024 Dec 24;26(1):3. doi: 10.3390/ijms26010003.
3
Natural products for the prevention and treatment of kidney disease.天然产物在肾脏病防治中的应用。
Phytomedicine. 2018 Nov 15;50:50-60. doi: 10.1016/j.phymed.2018.09.182. Epub 2018 Sep 17.
4
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.TGF-β/Smad 失调在 CKD 进展中的核心作用及其治疗的潜在靶点。
Biomed Pharmacother. 2018 May;101:670-681. doi: 10.1016/j.biopha.2018.02.090. Epub 2018 Mar 22.
5
Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.基于网络药理学的研究与实验验证预测肾康注射液治疗慢性肾脏病的作用机制。
J Ethnopharmacol. 2020 Jan 10;246:112128. doi: 10.1016/j.jep.2019.112128. Epub 2019 Aug 3.
6
The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.晚期慢性肾脏病中表型与脂肪酸代谢之间的联系。
Nephrol Dial Transplant. 2017 Jul 1;32(7):1154-1166. doi: 10.1093/ndt/gfw415.
7
Traditional Chinese medicine and plant-derived natural products in regulating triglyceride metabolism: Mechanisms and therapeutic potential.中药和植物源性天然产物在调节甘油三酯代谢中的作用机制及治疗潜力。
Pharmacol Res. 2024 Oct;208:107387. doi: 10.1016/j.phrs.2024.107387. Epub 2024 Aug 30.
8
Atorvastatin Improves Hepatic Lipid Metabolism and Protects Renal Damage in Adenine-Induced Chronic Kidney Disease in Sprague-Dawley Rats.阿托伐他汀改善腺嘌呤诱导的慢性肾脏病 Sprague-Dawley 大鼠的肝脂代谢并保护肾脏损伤。
Biomed Res Int. 2019 Nov 5;2019:8714363. doi: 10.1155/2019/8714363. eCollection 2019.
9
Podocyte Lipotoxicity in CKD.足细胞脂毒性与慢性肾脏病。
Kidney360. 2021 Feb 26;2(4):755-762. doi: 10.34067/KID.0006152020. eCollection 2021 Apr 29.
10
Protective Effects of Black Cumin () and Its Bioactive Constituent, Thymoquinone against Kidney Injury: An Aspect on Pharmacological Insights.黑孜然()及其生物活性成分百里醌对肾损伤的保护作用:药理学研究进展。
Int J Mol Sci. 2021 Aug 23;22(16):9078. doi: 10.3390/ijms22169078.

本文引用的文献

1
Correction to "Diosgenin Reduces Acute Kidney Injury and Ameliorates the Progression to Chronic Kidney Disease by Modifying the NOX4/p65 Signaling Pathways".《薯蓣皂苷元通过调节NOX4/p65信号通路减轻急性肾损伤并改善向慢性肾病的进展》的更正
J Agric Food Chem. 2024 Oct 30;72(43):24130. doi: 10.1021/acs.jafc.4c09385. Epub 2024 Oct 19.
2
Diosgenin Reduces Acute Kidney Injury and Ameliorates the Progression to Chronic Kidney Disease by Modifying the NOX4/p65 Signaling Pathways.薯蓣皂苷元通过调节 NOX4/p65 信号通路减轻急性肾损伤并改善其向慢性肾脏病的进展。
J Agric Food Chem. 2024 Aug 7;72(31):17444-17454. doi: 10.1021/acs.jafc.4c04183. Epub 2024 Jul 29.
3
Eltroxin and Hesperidin mitigate testicular and renal damage in hypothyroid rats: amelioration of oxidative stress through PPARγ and Nrf2/HO-1 signaling pathway.
左旋甲状腺素和橙皮苷减轻甲状腺功能减退大鼠的睾丸和肾脏损伤:通过PPARγ和Nrf2/HO-1信号通路改善氧化应激。
Lab Anim Res. 2024 May 14;40(1):19. doi: 10.1186/s42826-024-00204-8.
4
The role of PI3K/Akt signaling pathway in chronic kidney disease.PI3K/Akt 信号通路在慢性肾脏病中的作用。
Int Urol Nephrol. 2024 Aug;56(8):2623-2633. doi: 10.1007/s11255-024-03989-8. Epub 2024 Mar 18.
5
NRF2 in kidney physiology and disease.NRF2 在肾脏生理学和疾病中的作用。
Physiol Rep. 2024 Mar;12(5):e15961. doi: 10.14814/phy2.15961.
6
Tubular deficiency of ABCA1 augments cholesterol- and Na-dependent effects on systemic blood pressure in male mice.ABCA1 管状缺陷增强了雄性小鼠胆固醇和钠依赖性的全身血压效应。
Am J Physiol Renal Physiol. 2024 Feb 1;326(2):F265-F277. doi: 10.1152/ajprenal.00154.2023. Epub 2023 Dec 28.
7
Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidation.二氢杨梅素通过促进脂肪酸氧化来防止慢性肾脏病中的肾纤维化发展。
Phytother Res. 2024 Feb;38(2):839-855. doi: 10.1002/ptr.8085. Epub 2023 Dec 11.
8
Fatty acids and inflammatory stimuli induce expression of long-chain acyl-CoA synthetase 1 to promote lipid remodeling in diabetic kidney disease.脂肪酸和炎症刺激可诱导长链脂酰辅酶A合成酶1的表达,以促进糖尿病肾病中的脂质重塑。
J Biol Chem. 2024 Jan;300(1):105502. doi: 10.1016/j.jbc.2023.105502. Epub 2023 Nov 26.
9
Rutin ameliorate PFOA induced renal damage by reducing oxidative stress and improving lipid metabolism.芦丁通过降低氧化应激和改善脂质代谢来减轻 PFOS 诱导的肾脏损伤。
J Nutr Biochem. 2024 Jan;123:109501. doi: 10.1016/j.jnutbio.2023.109501. Epub 2023 Oct 25.
10
Acetyl-CoA synthetase 2 promotes diabetic renal tubular injury in mice by rewiring fatty acid metabolism through SIRT1/ChREBP pathway.乙酰辅酶 A 合成酶 2 通过 SIRT1/ChREBP 通路重排脂肪酸代谢促进小鼠糖尿病肾小管损伤。
Acta Pharmacol Sin. 2024 Feb;45(2):366-377. doi: 10.1038/s41401-023-01160-0. Epub 2023 Sep 28.